Moreover, clinic-genomic data revealed that HSP27 was more strongly involved in cancer prognosis than EGFR or AKT alone, and that overexpression of HSP27 potentiated negative effects in NSCLC patients. Here, AKT1 is linked to non-small cell lung carcinoma.